Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

325 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of glutamate positive modulators on cognitive deficits in schizophrenia: a systematic review and meta-analysis of double-blind randomized controlled trials.
Iwata Y, Nakajima S, Suzuki T, Keefe RS, Plitman E, Chung JK, Caravaggio F, Mimura M, Graff-Guerrero A, Uchida H. Iwata Y, et al. Among authors: keefe rs. Mol Psychiatry. 2015 Oct;20(10):1151-60. doi: 10.1038/mp.2015.68. Epub 2015 Jun 16. Mol Psychiatry. 2015. PMID: 26077694 Free PMC article. Review.
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS, Seidman LJ, Christensen BK, Hamer RM, Sharma T, Sitskoorn MM, Lewine RR, Yurgelun-Todd DA, Gur RC, Tohen M, Tollefson GD, Sanger TM, Lieberman JA. Keefe RS, et al. Am J Psychiatry. 2004 Jun;161(6):985-95. doi: 10.1176/appi.ajp.161.6.985. Am J Psychiatry. 2004. PMID: 15169686 Clinical Trial.
Effectiveness of olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia after discontinuing perphenazine: a CATIE study.
Stroup TS, Lieberman JA, McEvoy JP, Swartz MS, Davis SM, Capuano GA, Rosenheck RA, Keefe RS, Miller AL, Belz I, Hsiao JK; CATIE Investigators. Stroup TS, et al. Among authors: keefe rs. Am J Psychiatry. 2007 Mar;164(3):415-27. doi: 10.1176/ajp.2007.164.3.415. Am J Psychiatry. 2007. PMID: 17329466 Clinical Trial.
Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.
Keefe RS, Bilder RM, Davis SM, Harvey PD, Palmer BW, Gold JM, Meltzer HY, Green MF, Capuano G, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Davis CE, Hsiao JK, Lieberman JA; CATIE Investigators; Neurocognitive Working Group. Keefe RS, et al. Arch Gen Psychiatry. 2007 Jun;64(6):633-47. doi: 10.1001/archpsyc.64.6.633. Arch Gen Psychiatry. 2007. PMID: 17548746 Clinical Trial.
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
Keefe RS, Malhotra AK, Meltzer HY, Kane JM, Buchanan RW, Murthy A, Sovel M, Li C, Goldman R. Keefe RS, et al. Neuropsychopharmacology. 2008 May;33(6):1217-28. doi: 10.1038/sj.npp.1301499. Epub 2007 Jul 11. Neuropsychopharmacology. 2008. PMID: 17625502 Clinical Trial.
Cognition as an outcome measure in schizophrenia.
Kraus MS, Keefe RS. Kraus MS, et al. Among authors: keefe rs. Br J Psychiatry Suppl. 2007 Aug;50:s46-51. doi: 10.1192/bjp.191.50.s46. Br J Psychiatry Suppl. 2007. PMID: 18019044 Review.
325 results